Physician profile
Allan Lipkowitz
NPI 1770531394
$3,788.98
in general payments reported to CMS, 2019-2025
12 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.82 · 2020: $18.83 · 2021: $197 · 2022: $856 · 2023: $1,384 · 2024: $633 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,112.85 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $431.44 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Boston Scientific Corporation | $412.88 | 2022-2025 | Embold Fibered, Eluvia |
| Penumbra, INC. | $271.26 | 2022-2023 | Indigo System |
| Siemens Medical Solutions USA, INC. | $186.09 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $128.84 | 2023 | Venovo |
| Shockwave Medical, INC | $99.24 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $76.22 | 2023 | Camzyos |
| Merck Sharp & Dohme LLC | $22.65 | 2021 | |
| Cardinal Health 200 LLC | $18.83 | 2020 | |
| Covidien LP | $15.24 | 2019 | |
| Terumo Medical Corporation | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Lipkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.